DRIO
ANALYST COVERAGE9 analysts
BUY
+85.4%upside to target
L $7.50
Med $14.00consensus
H $16.00
Buy
889%
Hold
111%
8 Buy (89%)1 Hold (11%)0 Sell (0%)
Full report →
PRICE
Prev Close
8.00
Open
8.11
Day Range7.12 – 8.11
7.12
8.11
52W Range5.94 – 17.74
5.94
17.74
14% of range
VOLUME & SIZE
Avg Volume
12.2K
FUNDAMENTALS
P/E Ratio
-0.9x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.33
Market-like
TECHNICAL
RSI (14)
48
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 131 days
Sep 30

DRIO News

About

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the Company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Its cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease.

Industry
Surgical and Medical Instrument Manufacturing
Claudia LeviContent & Communications Manager
Dov OppenheimCo-Founder & Production Chief
Kat ParrellaInvestor Relations Manager
Lara DodoChief Operations Officer
Zoe HarrisonVP of Accounting & Corporate Development
Michal Aberman-ShimonChief People Officer
Erez RaphaelChief Executive Officer & Director
Rob HalpernSVP of Marketing
Steven C. NelsonPresident & Chief Commercial Officer
Chen Franco-YehudaChief Financial Officer, Treasurer & Secretary
Mona DeanChief Compliance Officer
Omar ManejwalaChief Medical Officer